Secondary Pharmacological Prevention of Coronary Artery Disease among Patients Submitted to Clinical Management, Percutaneous Coronary Intervention, or Coronary Artery Bypass Graft Surgery. - Lucca MB; Fuchs FC; Almeida AS; Wainstein MV; Fuchs FD; Fuchs SC (Arquivos brasileiros de cardiologia, 2023)